Nerve Repair and Regeneration Market by Product (Neurostimulation and Neuromodulation Devices, External Neurostimulation Devices and Biomaterials), Application (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, and Stem Cell Therapy), End-User (Hospitals & Clinics and Ambulatory Surgery Centres) Geography (North America, Europe, Asia Pacific, and RoW)- Global Opportunity Analysis and Industry Forecast up to 2026
Nerves are collective neurons, which help in sending messages from one body part to another part like signals. Injuries can cause damage to nerve cells and may not be able to send signals to and from the brain. Nerve damage can cause due to the pressure, stretching, or cutting of a nerve. Nerve repair and regeneration process can help to restore the nerves to the normal condition. Globally, major factors contributing to the Nerve repair and regeneration market growth include increasing number of nerve injuries, rapidly increasing old population where the nerves are very sensitive in this group as well as the rapidly growing neurological disorders. However, the lack of trained professionals and strict regulations are constraints in the market growth. The Nerve Repair and Regeneration market is predicted to reach $16.89 Billion by 2026 from $8.62 Billion in 2020, at a CAGR of ~11.8% during the forecast period.
The Nerve Repair and Regeneration market is segmented based on product, application, end-user, and geography.
Based on Product:
Further, based on application neurostimulation and neuromodulation segment is expected to have the largest share in the market due to the rapidly increasing neurological disorders such as epilepsy, Alzheimer's disease, and other dementias and growing occurrences of peripheral nerve injuries.
The nerve repair and regeneration market, based on end-users the market is segmented into hospitals and clinics and ambulatory surgery centers. Hospitals segment accounted for the largest share in the market due to the increasing number of nerve repair and nerve surgery procedures in hospitals, increased old population, and well-established healthcare infrastructure.
On the bases of geography, the market is segmented into four regions includes North America, Europe, APAC, and RoW. North America is dominating the market growth due to the increased cases of nerve injuries, well-established healthcare centers in this region, and high investments in the healthcare industry in this region are factors solidifying the growth.
Globally, the nerve repair and regeneration market is expanding due to the increasing neurological disorders; emerging technologies in the field of neurological surgeries, increasing elderly population in all over the world are the factors driving the nerve repair and regeneration market. Emerging countries are expected to be the future markets and give a new opportunity for market growth. Somehow, difficulties may occur in treating the large nerve gaps, and this is the challenge for the market growth.
The key market players in the Nerve Repair and Regeneration market are Livanova, Orthomed, Axogen, Baxter, Integra Lifescience, Abbott Laboratories, Boston Scientific, Nevro, Stryker, Medtronic, Polyganics, and Neuropace.
The constricted regulations and time-consuming approval process are the major challenges in the nerve repair and regeneration market. However, the advanced stem-cell therapy in the nerve the market provides the opportunity for the nerve repair and regeneration market. This report helps to understand the key market trends, market players strategies, and end-user analysis.
The Nerve Repair and Regeneration market is segmented based on product, application, end-user, and geography.
Based on Product:
- Neurostimulation and Neuromodulation Devices
- Internal Neurostimulation Devices
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neurostimulation Devices
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Biomaterials
- Nerve Conduits
- Nerve Protectors
- Nerve Wraps
- Nerve Connectors
- Neurostimulation and Neuromodulation Surgeries
- Internal Neurostimulation and Neuromodulation Surgeries
- External Neurostimulation and Neuromodulation Surgeries
- Direct Nerve Repair/Neurorrhaphy
- Epineural Repair
- Perineural Repair
- Group Fascicular Repair
- Nerve Grafting
- Autografts
- Allografts
- Xenografts
- Stem Cell Therapy
- Hospitals & Clinics
- Ambulatory Surgery Centres
- North America
- Europe
- Asia Pacific
- Rest of the World
Further, based on application neurostimulation and neuromodulation segment is expected to have the largest share in the market due to the rapidly increasing neurological disorders such as epilepsy, Alzheimer's disease, and other dementias and growing occurrences of peripheral nerve injuries.
The nerve repair and regeneration market, based on end-users the market is segmented into hospitals and clinics and ambulatory surgery centers. Hospitals segment accounted for the largest share in the market due to the increasing number of nerve repair and nerve surgery procedures in hospitals, increased old population, and well-established healthcare infrastructure.
On the bases of geography, the market is segmented into four regions includes North America, Europe, APAC, and RoW. North America is dominating the market growth due to the increased cases of nerve injuries, well-established healthcare centers in this region, and high investments in the healthcare industry in this region are factors solidifying the growth.
Globally, the nerve repair and regeneration market is expanding due to the increasing neurological disorders; emerging technologies in the field of neurological surgeries, increasing elderly population in all over the world are the factors driving the nerve repair and regeneration market. Emerging countries are expected to be the future markets and give a new opportunity for market growth. Somehow, difficulties may occur in treating the large nerve gaps, and this is the challenge for the market growth.
The key market players in the Nerve Repair and Regeneration market are Livanova, Orthomed, Axogen, Baxter, Integra Lifescience, Abbott Laboratories, Boston Scientific, Nevro, Stryker, Medtronic, Polyganics, and Neuropace.
The constricted regulations and time-consuming approval process are the major challenges in the nerve repair and regeneration market. However, the advanced stem-cell therapy in the nerve the market provides the opportunity for the nerve repair and regeneration market. This report helps to understand the key market trends, market players strategies, and end-user analysis.
- The competitive analysis of the major players enables users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions and joint ventures of the key players
- This report also provides the portfolio analysis, capability analysis of the leading players
- Quantitative analysis of the market enables users to understand the actual facts of the market across four major regions
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Neurostimulation and Neuromodulation Devices
5.2.1. Internal Neurostimulation Devices
5.2.1.1. Spinal Cord Stimulation
5.2.1.2. Deep Brain Stimulation
5.2.1.3. Vagus Nerve Stimulation
5.2.1.4. Sacral Nerve Stimulation
5.2.1.5. Gastric Electrical Stimulation
5.2.2. External Neurostimulation Devices
5.2.2.1. Transcutaneous Electrical Nerve Stimulation
5.2.2.2. Transcranial Magnetic Stimulation
5.3. Biomaterials
5.3.1. Nerve Conduits
5.3.2. Nerve Protectors
5.3.3. Nerve Wraps
5.3.4. Nerve Connectors
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Neurostimulation and Neuromodulation Surgeries
6.2.1. Internal
6.2.2. External
6.3. Direct Nerve Repair/Neurorrhaphy
6.3.1. Epineural Repair
6.3.2. Perineural Repair
6.3.3. Group Fascicular Repair
6.4. Nerve Grafting
6.4.1. Autografts
6.4.2. Allografts
6.4.3. Xenografts
6.5. Stem Cell Therapy
7. END USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Hospitals & Clinics
7.3. Ambulatory Surgery Centers
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.3. Mergers and Acquisitions, Legal, Awards, Partnerships
9.4. Product Launches and execution
10. VENDOR PROFILES
10.1. Axogen
10.1.1. Overview
10.1.2. Product Offerings
10.1.3. Geographic Revenue
10.1.4. Business Units
10.1.5. Developments
10.1.6. Business Strategy
10.2. Baxter
10.2.1. Overview
10.2.2. Product Offerings
10.2.3. Geographic Revenue
10.2.4. Business Units
10.2.5. Developments
10.2.6. Business Strategy
10.3. Boston Scientific
10.3.1. Overview
10.3.2. Product Offerings
10.3.3. Geographic Revenue
10.3.4. Business Units
10.3.5. Developments
10.3.6. Business Strategy
10.4. Livanova
10.4.1. Overview
10.4.2. Product Offerings
10.4.3. Geographic Revenue
10.4.4. Business Units
10.4.5. Developments
10.4.6. Business Strategy
10.5. Integra Lifesciences
10.5.1. Overview
10.5.2. Product Offerings
10.5.3. Geographic Revenue
10.5.4. Business Units
10.5.5. Developments
10.5.6. Business Strategy
10.6. Medtronic
10.6.1. Overview
10.6.2. Product Offerings
10.6.3. Geographic Revenue
10.6.4. Business Units
10.6.5. Developments
10.6.6. Business Strategy
10.7. Abbott Laboratories
10.7.1. Overview
10.7.2. Product Offerings
10.7.3. Geographic Revenue
10.7.4. Business Units
10.7.5. Developments
10.7.6. Business Strategy
10.8. Stryker
10.8.1. Overview
10.8.2. Product Offerings
10.8.3. Geographic Revenue
10.8.4. Business Units
10.8.5. Developments
10.8.6. Business Strategy
10.9. Polyganics
10.9.1. Overview
10.9.2. Product Offerings
10.9.3. Geographic Revenue
10.9.4. Business Units
10.9.5. Developments
10.9.6. Business Strategy
10.10. Nevro
10.10.1. Overview
10.10.2. Product Offerings
10.10.3. Geographic Revenue
10.10.4. Business Units
10.10.5. Developments
10.10.6. Business Strategy
11. COMPANIES TO WATCH
11.1. Neuropace
11.1.1. Overview
11.1.2. Market
11.1.3. Business Strategy
11.2. Orthomed
11.2.1. Overview
11.2.2. Market
11.2.3. Business Strategy
11.3. Nevro
11.3.1. Overview
11.3.2. Market
11.3.3. Business Strategy
12. ANALYST OPINION
13. ANNEXURE
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Neurostimulation and Neuromodulation Devices
5.2.1. Internal Neurostimulation Devices
5.2.1.1. Spinal Cord Stimulation
5.2.1.2. Deep Brain Stimulation
5.2.1.3. Vagus Nerve Stimulation
5.2.1.4. Sacral Nerve Stimulation
5.2.1.5. Gastric Electrical Stimulation
5.2.2. External Neurostimulation Devices
5.2.2.1. Transcutaneous Electrical Nerve Stimulation
5.2.2.2. Transcranial Magnetic Stimulation
5.3. Biomaterials
5.3.1. Nerve Conduits
5.3.2. Nerve Protectors
5.3.3. Nerve Wraps
5.3.4. Nerve Connectors
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Neurostimulation and Neuromodulation Surgeries
6.2.1. Internal
6.2.2. External
6.3. Direct Nerve Repair/Neurorrhaphy
6.3.1. Epineural Repair
6.3.2. Perineural Repair
6.3.3. Group Fascicular Repair
6.4. Nerve Grafting
6.4.1. Autografts
6.4.2. Allografts
6.4.3. Xenografts
6.5. Stem Cell Therapy
7. END USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Hospitals & Clinics
7.3. Ambulatory Surgery Centers
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.3. Mergers and Acquisitions, Legal, Awards, Partnerships
9.4. Product Launches and execution
10. VENDOR PROFILES
10.1. Axogen
10.1.1. Overview
10.1.2. Product Offerings
10.1.3. Geographic Revenue
10.1.4. Business Units
10.1.5. Developments
10.1.6. Business Strategy
10.2. Baxter
10.2.1. Overview
10.2.2. Product Offerings
10.2.3. Geographic Revenue
10.2.4. Business Units
10.2.5. Developments
10.2.6. Business Strategy
10.3. Boston Scientific
10.3.1. Overview
10.3.2. Product Offerings
10.3.3. Geographic Revenue
10.3.4. Business Units
10.3.5. Developments
10.3.6. Business Strategy
10.4. Livanova
10.4.1. Overview
10.4.2. Product Offerings
10.4.3. Geographic Revenue
10.4.4. Business Units
10.4.5. Developments
10.4.6. Business Strategy
10.5. Integra Lifesciences
10.5.1. Overview
10.5.2. Product Offerings
10.5.3. Geographic Revenue
10.5.4. Business Units
10.5.5. Developments
10.5.6. Business Strategy
10.6. Medtronic
10.6.1. Overview
10.6.2. Product Offerings
10.6.3. Geographic Revenue
10.6.4. Business Units
10.6.5. Developments
10.6.6. Business Strategy
10.7. Abbott Laboratories
10.7.1. Overview
10.7.2. Product Offerings
10.7.3. Geographic Revenue
10.7.4. Business Units
10.7.5. Developments
10.7.6. Business Strategy
10.8. Stryker
10.8.1. Overview
10.8.2. Product Offerings
10.8.3. Geographic Revenue
10.8.4. Business Units
10.8.5. Developments
10.8.6. Business Strategy
10.9. Polyganics
10.9.1. Overview
10.9.2. Product Offerings
10.9.3. Geographic Revenue
10.9.4. Business Units
10.9.5. Developments
10.9.6. Business Strategy
10.10. Nevro
10.10.1. Overview
10.10.2. Product Offerings
10.10.3. Geographic Revenue
10.10.4. Business Units
10.10.5. Developments
10.10.6. Business Strategy
11. COMPANIES TO WATCH
11.1. Neuropace
11.1.1. Overview
11.1.2. Market
11.1.3. Business Strategy
11.2. Orthomed
11.2.1. Overview
11.2.2. Market
11.2.3. Business Strategy
11.3. Nevro
11.3.1. Overview
11.3.2. Market
11.3.3. Business Strategy
12. ANALYST OPINION
13. ANNEXURE
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 2. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2020-2026 (USD MILLION)
TABLE 3. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 5. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SPINAL CORD STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DEEP BRAIN STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR VAGUS NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 8. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SACRAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GASTRIC ELECTRICAL STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 12. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCRANIAL MAGNETIC STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 13. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY TYPE, 2020-2026 (USD MILLION)
TABLE 14. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONDUITS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE PROTECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE WRAPS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 18. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONNECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 20. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2020-2026 (USD MILLION)
TABLE 21. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 22. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 23. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 24. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY TYPE, 2020-2026 (USD MILLION)
TABLE 25. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 26. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EPINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 27. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR PERINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 28. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GROUP FASCICULAR REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 29. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY TYPE, 2020-2026 (USD MILLION)
TABLE 30. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 31. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AUTOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 32. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR ALLOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 33. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR XENOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 34. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR STEM CELL THERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 35. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 36. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 37. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AMBULATORY SURGERY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 38. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 39. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 40. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 41. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 42. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 43. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 44. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 45. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 46. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 47. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 49. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 50. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 51. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 52. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 53. AXOGEN: OVERVIEW
TABLE 54. AXOGEN: STRATEGIC SNAPSHOT
TABLE 55. AXOGEN: BUSINESS FOCUS
TABLE 56. AXOGEN: APPLICATION/SERVICE PORTFOLIO
TABLE 57. BAXTER: OVERVIEW
TABLE 58. BAXTER: STRATEGIC SNAPSHOT
TABLE 59. BAXTER: BUSINESS FOCUS
TABLE 60. BAXTER: APPLICATION/SERVICE PORTFOLIO
TABLE 61. BOSTON SCIENTIFIC: OVERVIEW
TABLE 62. BOSTON SCIENTIFIC: STRATEGIC SNAPSHOT
TABLE 63. BOSTON SCIENTIFIC: BUSINESS FOCUS
TABLE 64. BOSTON SCIENTIFIC: APPLICATION/SERVICE PORTFOLIO
TABLE 65. LIVANOVA: OVERVIEW
TABLE 66. LIVANOVA: STRATEGIC SNAPSHOT
TABLE 67. LIVANOVA: BUSINESS FOCUS
TABLE 68. LIVANOVA: APPLICATION/SERVICE PORTFOLIO
TABLE 69. INTEGRA LIFESCIENCES: OVERVIEW
TABLE 70. INTEGRA LIFESCIENCES: STRATEGIC SNAPSHOT
TABLE 71. INTEGRA LIFESCIENCES: BUSINESS FOCUS
TABLE 72. INTEGRA LIFESCIENCES: APPLICATION/SERVICE PORTFOLIO
TABLE 73. MEDTRONIC: OVERVIEW
TABLE 74. MEDTRONIC: STRATEGIC SNAPSHOT
TABLE 75. MEDTRONIC: BUSINESS FOCUS
TABLE 76. MEDTRONIC: APPLICATION/SERVICE PORTFOLIO
TABLE 77. ABBOTT LABORATORIES: OVERVIEW
TABLE 78. ABBOTT LABORATORIES: STRATEGIC SNAPSHOT
TABLE 79. ABBOTT LABORATORIES: BUSINESS FOCUS
TABLE 80. ABBOTT LABORATORIES: APPLICATION/SERVICE PORTFOLIO
TABLE 81. STRYKER: OVERVIEW
TABLE 82. STRYKER: STRATEGIC SNAPSHOT
TABLE 83. STRYKER: BUSINESS FOCUS
TABLE 84. STRYKER: APPLICATION/SERVICE PORTFOLIO
TABLE 85. NEVRO: OVERVIEW
TABLE 86. NEVRO: STRATEGIC SNAPSHOT
TABLE 87. NEVRO: BUSINESS FOCUS
TABLE 88. NEVRO: APPLICATION/SERVICE PORTFOLIO
TABLE 89. ORTHOMED: OVERVIEW
TABLE 90. ORTHOMED: STRATEGIC SNAPSHOT
TABLE 91. ORTHOMED: BUSINESS FOCUS
TABLE 92. ORTHOMED: APPLICATION/SERVICE PORTFOLIO
TABLE 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 2. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2020-2026 (USD MILLION)
TABLE 3. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 4. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 5. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SPINAL CORD STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 6. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DEEP BRAIN STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 7. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR VAGUS NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 8. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SACRAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 9. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GASTRIC ELECTRICAL STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 10. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 11. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 12. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCRANIAL MAGNETIC STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 13. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY TYPE, 2020-2026 (USD MILLION)
TABLE 14. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 15. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONDUITS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 16. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE PROTECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 17. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE WRAPS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 18. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONNECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 19. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 20. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2020-2026 (USD MILLION)
TABLE 21. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 22. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 23. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 24. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY TYPE, 2020-2026 (USD MILLION)
TABLE 25. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 26. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EPINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 27. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR PERINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 28. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GROUP FASCICULAR REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 29. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY TYPE, 2020-2026 (USD MILLION)
TABLE 30. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 31. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AUTOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 32. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR ALLOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 33. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR XENOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 34. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR STEM CELL THERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 35. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 36. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 37. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AMBULATORY SURGERY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
TABLE 38. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 39. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 40. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 41. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 42. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 43. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 44. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 45. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 46. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
TABLE 47. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 48. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 49. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 50. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
TABLE 51. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
TABLE 52. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
TABLE 53. AXOGEN: OVERVIEW
TABLE 54. AXOGEN: STRATEGIC SNAPSHOT
TABLE 55. AXOGEN: BUSINESS FOCUS
TABLE 56. AXOGEN: APPLICATION/SERVICE PORTFOLIO
TABLE 57. BAXTER: OVERVIEW
TABLE 58. BAXTER: STRATEGIC SNAPSHOT
TABLE 59. BAXTER: BUSINESS FOCUS
TABLE 60. BAXTER: APPLICATION/SERVICE PORTFOLIO
TABLE 61. BOSTON SCIENTIFIC: OVERVIEW
TABLE 62. BOSTON SCIENTIFIC: STRATEGIC SNAPSHOT
TABLE 63. BOSTON SCIENTIFIC: BUSINESS FOCUS
TABLE 64. BOSTON SCIENTIFIC: APPLICATION/SERVICE PORTFOLIO
TABLE 65. LIVANOVA: OVERVIEW
TABLE 66. LIVANOVA: STRATEGIC SNAPSHOT
TABLE 67. LIVANOVA: BUSINESS FOCUS
TABLE 68. LIVANOVA: APPLICATION/SERVICE PORTFOLIO
TABLE 69. INTEGRA LIFESCIENCES: OVERVIEW
TABLE 70. INTEGRA LIFESCIENCES: STRATEGIC SNAPSHOT
TABLE 71. INTEGRA LIFESCIENCES: BUSINESS FOCUS
TABLE 72. INTEGRA LIFESCIENCES: APPLICATION/SERVICE PORTFOLIO
TABLE 73. MEDTRONIC: OVERVIEW
TABLE 74. MEDTRONIC: STRATEGIC SNAPSHOT
TABLE 75. MEDTRONIC: BUSINESS FOCUS
TABLE 76. MEDTRONIC: APPLICATION/SERVICE PORTFOLIO
TABLE 77. ABBOTT LABORATORIES: OVERVIEW
TABLE 78. ABBOTT LABORATORIES: STRATEGIC SNAPSHOT
TABLE 79. ABBOTT LABORATORIES: BUSINESS FOCUS
TABLE 80. ABBOTT LABORATORIES: APPLICATION/SERVICE PORTFOLIO
TABLE 81. STRYKER: OVERVIEW
TABLE 82. STRYKER: STRATEGIC SNAPSHOT
TABLE 83. STRYKER: BUSINESS FOCUS
TABLE 84. STRYKER: APPLICATION/SERVICE PORTFOLIO
TABLE 85. NEVRO: OVERVIEW
TABLE 86. NEVRO: STRATEGIC SNAPSHOT
TABLE 87. NEVRO: BUSINESS FOCUS
TABLE 88. NEVRO: APPLICATION/SERVICE PORTFOLIO
TABLE 89. ORTHOMED: OVERVIEW
TABLE 90. ORTHOMED: STRATEGIC SNAPSHOT
TABLE 91. ORTHOMED: BUSINESS FOCUS
TABLE 92. ORTHOMED: APPLICATION/SERVICE PORTFOLIO
LIST OF FIGURES
CHART. 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 2. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2020-2026 (USD MILLION)
CHART. 3. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 4. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 5. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SPINAL CORD STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 6. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DEEP BRAIN STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 7. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR VAGUS NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 8. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SACRAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 9. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GASTRIC ELECTRICAL STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 10. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 11. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 12. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCRANIAL MAGNETIC STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 13. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY TYPE, 2020-2026 (USD MILLION)
CHART. 14. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 15. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONDUITS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 16. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE PROTECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 17. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE WRAPS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 18. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONNECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 19. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 20. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2020-2026 (USD MILLION)
CHART. 21. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 22. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 23. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 24. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY TYPE, 2020-2026 (USD MILLION)
CHART. 25. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 26. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EPINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 27. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR PERINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 28. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GROUP FASCICULAR REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 29. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY TYPE, 2020-2026 (USD MILLION)
CHART. 30. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 31. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AUTOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 32. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR ALLOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 33. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR XENOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 34. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR STEM CELL THERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 35. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 36. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 37. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AMBULATORY SURGERY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 38. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 39. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 40. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 41. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 42. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 43. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 44. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 45. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 46. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 47. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 48. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 49. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 50. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 51. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 52. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 1. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 2. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY TYPE, 2020-2026 (USD MILLION)
CHART. 3. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 4. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 5. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SPINAL CORD STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 6. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DEEP BRAIN STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 7. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR VAGUS NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 8. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR SACRAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 9. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GASTRIC ELECTRICAL STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 10. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL NEUROSTIMULATION DEVICES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 11. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 12. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR TRANSCRANIAL MAGNETIC STIMULATION, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 13. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY TYPE, 2020-2026 (USD MILLION)
CHART. 14. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR BIOMATERIALS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 15. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONDUITS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 16. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE PROTECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 17. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE WRAPS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 18. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE CONNECTORS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 19. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 20. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY TYPE, 2020-2026 (USD MILLION)
CHART. 21. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NEUROSTIMULATION AND NEUROMODULATION SURGERIES, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 22. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR INTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 23. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EXTERNAL, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 24. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY TYPE, 2020-2026 (USD MILLION)
CHART. 25. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 26. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR EPINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 27. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR PERINEURAL REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 28. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR GROUP FASCICULAR REPAIR, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 29. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY TYPE, 2020-2026 (USD MILLION)
CHART. 30. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR NERVE GRAFTING, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 31. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AUTOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 32. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR ALLOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 33. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR XENOGRAFTS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 34. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR STEM CELL THERAPY, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 35. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 36. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 37. GLOBAL NERVE REPAIR AND REGENERATION MARKET VALUE FOR AMBULATORY SURGERY CENTERS, BY GEOGRAPHY, 2020-2026 (USD MILLION)
CHART. 38. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 39. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 40. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 41. NORTH AMERICA NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 42. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 43. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 44. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 45. EUROPE NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 46. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD MILLION)
CHART. 47. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 48. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 49. ASIA PACIFIC NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
CHART. 50. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD MILLION)
CHART. 51. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD MILLION)
CHART. 52. REST OF WORLD NERVE REPAIR AND REGENERATION MARKET VALUE, BY END USERS, 2020-2026 (USD MILLION)
